ScoreWhy is InDex Pharmaceuticals Holding AB ?
Unrated Stock - No Analysis Available
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
51.42%
EBIT Growth (5y)
-182.57%
EBIT to Interest (avg)
-66.30
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.20
Sales to Capital Employed (avg)
0.14
Tax Ratio
1.20%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0.61%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.73
EV to EBIT
-57.39
EV to EBITDA
-58.71
EV to Capital Employed
0.68
EV to Sales
103.82
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-1.18%
ROE (Latest)
-1.53%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend24What is working for the Company
OPERATING CASH FLOW(Y)
Highest at SEK -16.8 MM
NET SALES(HY)
Higher at SEK 22 MM
RAW MATERIAL COST(Y)
Fallen by -99.99% (YoY
CASH AND EQV(HY)
Highest at SEK 1,539.4 MM
OPERATING PROFIT(Q)
Highest at SEK 158.6 MM
PRE-TAX PROFIT(Q)
Highest at SEK 174.2 MM
NET PROFIT(Q)
Highest at SEK 173.5 MM
-8What is not working for the Company
INTEREST(HY)
At SEK 82.4 MM has Grown at 5,602.42%
Here's what is working for InDex Pharmaceuticals Holding AB
Pre-Tax Profit
At SEK 174.2 MM has Grown at 325.14%
over average net sales of the previous four periods of SEK -77.37 MMMOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (SEK MM)
Net Profit
At SEK 173.5 MM has Grown at 327.24%
over average net sales of the previous four periods of SEK -76.35 MMMOJO Watch
Near term Net Profit trend is very positive
Net Profit (SEK MM)
Net Sales
At SEK 22 MM has Grown at 101.21%
Year on Year (YoY)MOJO Watch
Near term sales trend is very positive
Net Sales (SEK MM)
Operating Cash Flow
Highest at SEK -16.8 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (SEK MM)
Net Sales
Higher at SEK 22 MM
than preceding 12 month period ended Jun 2025MOJO Watch
In the half year the company has already crossed sales of the previous twelve months
Net Sales (SEK MM)
Operating Profit
Highest at SEK 158.6 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (SEK MM)
Pre-Tax Profit
Highest at SEK 174.2 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (SEK MM)
Net Profit
Highest at SEK 173.5 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (SEK MM)
Cash and Eqv
Highest at SEK 1,539.4 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Raw Material Cost
Fallen by -99.99% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for InDex Pharmaceuticals Holding AB
Interest
At SEK 82.4 MM has Grown at 5,602.42%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (SEK MM)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
